Literature DB >> 33330991

High-grade tumours promote growth of other less-malignant tumours in the same prostate.

Sofia Halin Bergström1, Stina Rudolfsson2, Marie Lundholm1, Andreas Josefsson2, Pernilla Wikström1, Anders Bergh1.   

Abstract

Prostate cancer is a multifocal disease, but if and how individual prostate tumours influence each other is largely unknown. We therefore explored signs of direct or indirect tumour-tumour interactions in experimental models and patient samples. Low-metastatic AT1 and high-metastatic MatLyLu (MLL) Dunning rat prostate cancer cells were injected into separate lobes of the ventral prostate of immunocompetent rats. AT1 tumours growing in the same prostate as MLL tumours had increased tumour size and proliferation compared to AT1 tumours growing alone. In addition, the vasculature and macrophage density surrounding the AT1 tumours were increased by MLL tumour closeness. In patient prostatectomy samples, selected to contain an index tumour [tumour with the highest grade, International Society of Urological Pathology (ISUP) grade 1, 2, 3 or 4] and a low-grade satellite tumour (ISUP grade 1), cell proliferation in low-grade satellite tumours gradually increased with increasing histological grade of the index tumour. The density of blood vessels and CD68+ macrophages also increased around the low-grade satellite tumour if a high-grade index tumour was present. This suggests that high-grade tumours, by changing the prostate microenvironment, may increase the aggressiveness of low-grade lesions in the organ. Future studies are needed to explore the mechanisms behind tumour-tumour interactions and their clinical importance.
© 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.

Entities:  

Keywords:  CD68; Factor VIII; Ki67; angiogenesis; experimental rat prostate tumour model; high-grade prostate cancer; low-grade prostate cancer; multifocal primary prostate cancer; tumour instigator; tumour-associated macrophages

Year:  2021        PMID: 33330991      PMCID: PMC7986692          DOI: 10.1002/path.5604

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  28 in total

1.  Prostate cancer induces C/EBPβ expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome.

Authors:  Hanibal Adamo; Peter Hammarsten; Christina Hägglöf; Tove Dahl Scherdin; Lars Egevad; Pär Stattin; Sofia Halin Bergström; Anders Bergh
Journal:  Prostate       Date:  2018-12-11       Impact factor: 4.104

2.  Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative treatment.

Authors:  Andreas Josefsson; Pernilla Wikström; Torvald Granfors; Lars Egevad; Lars Karlberg; Pär Stattin; Anders Bergh
Journal:  Eur Urol       Date:  2005-10       Impact factor: 20.096

Review 3.  Metastasis as a systemic disease: molecular insights and clinical implications.

Authors:  Maša Alečković; Sandra S McAllister; Kornelia Polyak
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-06-14       Impact factor: 10.680

4.  Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening.

Authors:  Melissa Assel; Anders Dahlin; David Ulmert; Anders Bergh; Pär Stattin; Hans Lilja; Andrew J Vickers
Journal:  Eur Urol       Date:  2017-10-21       Impact factor: 20.096

Review 5.  The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis.

Authors:  Sandra S McAllister; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2014-08       Impact factor: 28.824

6.  Tracking the clonal origin of lethal prostate cancer.

Authors:  Michael C Haffner; Timothy Mosbruger; David M Esopi; Helen Fedor; Christopher M Heaphy; David A Walker; Nkosi Adejola; Meltem Gürel; Jessica Hicks; Alan K Meeker; Marc K Halushka; Jonathan W Simons; William B Isaacs; Angelo M De Marzo; William G Nelson; Srinivasan Yegnasubramanian
Journal:  J Clin Invest       Date:  2013-10-25       Impact factor: 14.808

7.  The evolutionary history of lethal metastatic prostate cancer.

Authors:  Christopher Foster; Douglas Easton; Ultan McDermott; David C Wedge; G Steven Bova; Gunes Gundem; Peter Van Loo; Barbara Kremeyer; Ludmil B Alexandrov; Jose M C Tubio; Elli Papaemmanuil; Daniel S Brewer; Heini M L Kallio; Gunilla Högnäs; Matti Annala; Kati Kivinummi; Victoria Goody; Calli Latimer; Sarah O'Meara; Kevin J Dawson; William Isaacs; Michael R Emmert-Buck; Matti Nykter; Zsofia Kote-Jarai; Hayley C Whitaker; David E Neal; Colin S Cooper; Rosalind A Eeles; Tapio Visakorpi; Peter J Campbell
Journal:  Nature       Date:  2015-04-01       Impact factor: 49.962

8.  Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer.

Authors:  Matthew K H Hong; Geoff Macintyre; David C Wedge; Peter Van Loo; Keval Patel; Sebastian Lunke; Ludmil B Alexandrov; Clare Sloggett; Marek Cmero; Francesco Marass; Dana Tsui; Stefano Mangiola; Andrew Lonie; Haroon Naeem; Nikhil Sapre; Pramit M Phal; Natalie Kurganovs; Xiaowen Chin; Michael Kerger; Anne Y Warren; David Neal; Vincent Gnanapragasam; Nitzan Rosenfeld; John S Pedersen; Andrew Ryan; Izhak Haviv; Anthony J Costello; Niall M Corcoran; Christopher M Hovens
Journal:  Nat Commun       Date:  2015-04-01       Impact factor: 14.919

9.  Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort.

Authors:  G Fisher; Z H Yang; S Kudahetti; H Møller; P Scardino; J Cuzick; D M Berney
Journal:  Br J Cancer       Date:  2013-01-17       Impact factor: 7.640

10.  Highly aggressive rat prostate tumors rapidly precondition regional lymph nodes for subsequent metastatic growth.

Authors:  Kerstin Strömvall; Marie Lundholm; Elin Thysell; Anders Bergh; Sofia Halin Bergström
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

View more
  1 in total

Review 1.  The Roles of Tumor-Associated Macrophages in Prostate Cancer.

Authors:  Chenglin Han; Yuxuan Deng; Wenchao Xu; Zhuo Liu; Tao Wang; Shaogang Wang; Jihong Liu; Xiaming Liu
Journal:  J Oncol       Date:  2022-09-07       Impact factor: 4.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.